Table 2 Efficacy of conventional and nano-formulations of Chlorfenapyr and Emamectin benzoate (recommended field rate) against Tetranychus urticae adults under semi-field conditions.
Formulations | No. of T. urticae/leaves | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Before Treatment | After 1 st Treatment | Corrected efficacy % | % of reduction | After 2nd treatment | Corrected efficacy % | % of reduction | After 3rd Treatment | Corrected efficacy % | % of reduction | |
CF | 245.7 ± 75.6 | 27.7 ± 5.3b | 93.6 | 88.7 | 18.2 ± 5.4b | 95.8 | 92.6 | 16.7 ± 8.7b | 95.6 | 93.2 |
CFNPs | 124.8 ± 63.7 | 4.8 ± 2.9b | 97.8 | 96.2 | 2.4 ± 2.5b | 98.9 | 98.1 | 19.1 ± 11.3b | 90.1 | 84.7 |
EB | 127.0 ± 33.3 | 15.6 ± 6.8b | 93.1 | 87.7 | 34.0 ± 22.6b | 84.9 | 73.2 | 16.8 ± 7.7b | 91.4 | 86.8 |
EBNPs | 204.6 ± 35.1 | 37.2 ± 7.2b | 89.7 | 81.8 | 25.1 ± 2.8b | 75.4 | 87.7 | 19.6 ± 9.8b | 93.8 | 90.4 |
Control | 86.7 ± 32.3 | 152.8 ± 37.9a | 154.2 ± 16.3a | 133.3 ± 20.3a | ||||||
F-values | 34.4 | 69.1 | 51.9 | |||||||
LSD | 32.3 | 23.2 | 22.6 | |||||||
df | 4 | 4 | 4 | |||||||
P-values | 0.0000*** | 0.0000*** | 0.0000*** | |||||||